The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Pin to quick picksAviva Share News (AV.)

Share Price Information for Aviva (AV.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 467.40
Bid: 467.20
Ask: 467.50
Change: 3.60 (0.78%)
Spread: 0.30 (0.064%)
Open: 464.40
High: 467.70
Low: 463.40
Prev. Close: 463.80
AV. Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TOP NEWS: Aviva "Simplifies" As 2019 To Be In Line With Board Views

Wed, 20th Nov 2019 08:23

(Alliance News) - Aviva PLC unveiled its new "simplification" strategy on Wednesday, saying it is going to begin operating with five divisions.

The five divisions are: Investments, Savings & Retirement; UK Life; General Insurance; Europe Life; and Asia Life.

The "simplification" is expected to result in GBP300 million in net savings by 2022, Aviva said, with a GBP1.5 billion reduction of debt.

"Aviva's focus is delivering sustainable growing returns to shareholders. Our forecast cash flows are more than sufficient to sustain our dividend, reduce debt and grow Aviva," Chief Executive Maurice Tulloch said.

Aviva's IS&R business will focus on retirement products for UK customers, which the insurer described as the "biggest financial challenge globally". UK Life, the company said, will focus on generating "significant" levels of cash flows, which will fund Aviva's dividend. UK Life will look to reinvest any company profits in new businesses.

General Insurance's first job will be to "strengthen" the company's personal lines and seek out "attractive" margins in commercial lines. Aviva said the business will focus on "speed, simplicity and efficiency".

Europe Life and Asia Life will run the Aviva's operations in their respective regions.

Aviva said it is keeping its Singapore and China businesses, believing they are "profitable businesses, delivering attractive growth and generating positive cash-flow".

The insurer continued: "We have agreed the sale of our stake in our Hong Kong joint venture, Blue, to our partner Hillhouse Capital, and we are in discussions with our partners in relation to our business in Vietnam and joint venture in Indonesia."

The FSTE 100-listed insurer said the overall strategy will allow it to "excel at fundamentals" and invest in sustainable growth. Over the next three years, Aviva is looking to invest GBP1.3 billion in the company.

Aviva added: "At the same time, we remain committed to our progressive dividend policy, our deleveraging plan and maintaining the financial strength of the group."

Turning to medium term financial targets, Aviva is guiding for a solvency II return on equity by 2022 of 12%. From 2019 to 2022, operating capital generation is expected to be GBP7.5 billion, with cash flows between GBP8.5 billion and GBP9.0 billion.

For 2019, the insurer's operating profit is expected to be "broadly" in line with management expectations. In 2018, Aviva reported an operating profit of GBP3.12 billion.

"Consistent with the operating trends reported in our 2019 interim results, we have seen continued progress in Canada and stronger sales in bulk purchase annuities, offset by weaker results in Aviva Investors and UK personal lines insurance," said Aviva.

Chief Executive Maurice Tulloch added: "Aviva is a business with ambition. We are investing in new services, new products and new technology. We expect growth, especially in higher return businesses such as General Insurance and Asia and also, from our new Investment, Savings & Retirement business.

"Our strategic review has been rigorous and thorough. I am committed to running Aviva better. We will be more commercially focused, manage costs rigorously and be more disciplined in how we invest. We will excel at the basics, giving customers a simpler, faster and more convenient service. Getting these fundamentals right will result in a simpler, stronger, better Aviva, while also improving returns for shareholders."

Shares in Aviva were 3.6% lower in London in early trading on Wednesday at 403.20 pence each.

By Paul McGowan; paulmcgowan@alliancenews.com

Copyright 2019 Alliance News Limited. All Rights Reserved.

More News
21 Sep 2023 12:52

IN BRIEF: Watchstone interim loss widens on costs of claim against PwC

Watchstone Group PLC - former insurance software provider originally called Quindell; now cash shell pursuing litigation claims - Pretax loss widens to GBP6.0 million in six months that ended June 30 from GBP2.1 million a year before. Has no revenue, so loss is due to higher administrative expenses. These primarily are legal costs, including GBP4.9 million for Watchstone's claim against PricewaterhouseCoopers LLP. The High Court dismissed Watchstone's claim, and while it seeks permission to appeal, Watchstone must pay PwC's legal costs, as well as its own. Other outstanding claims are against Aviva Canada, part of Aviva PLC, and against UK tax collector HMRC over the recovery of historic VAT. "We remain focussed on realising the group's remaining litigation assets as efficiently as possible and are confident of returning further cash sums to shareholders in due course," Watchstone says.

Read more
13 Sep 2023 17:01

LONDON MARKET CLOSE: FTSE 100 tips into red as UK economy shrinks

(Alliance News) - The FTSE 100 dipped into the red at the close on Wednesday, weighed down by news that the UK economy shrank more than expected in July, just one week before the Bank of England's next interest rate decision.

Read more
13 Sep 2023 11:49

LONDON MARKET MIDDAY: Stocks down as investors wait for US inflation

(Alliance News) - Stock prices in London were lower at midday Wednesday as investors eyed a key US inflation reading later in the day, ahead of the Federal Reserve's interest rate decision next week.

Read more
13 Sep 2023 08:57

LONDON MARKET OPEN: Stocks mixed ahead of key US inflation reading

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of a key US inflation reading, which might impact future interest rate decisions.

Read more
13 Sep 2023 08:48

TOP NEWS: Aviva gets GBP800 million from Singapore Life exit

(Alliance News) - Aviva PLC on Wednesday said it has agreed to sell its quarter ownership of Singapore Life Holdings Pte Ltd to fellow shareholder Sumitomo Life Insurance Co for a total of SGD1.4 billion, about GBP800 million.

Read more
13 Sep 2023 07:01

Aviva sells stake in Singlife, debt instruments to Sumitomo for £0.8bn

(Sharecast News) - UK insurer Aviva on Wednesday said it had agreed to sell its 25.9% stake in Singapore Life Holdings (Singlife), together with two debt instruments, to Sumitomo Life for £800m in cash.

Read more
11 Sep 2023 09:33

LONDON BROKER RATINGS: RBC cuts Melrose Industries to 'sector perform'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
7 Sep 2023 09:45

LONDON BROKER RATINGS: RBC ups ConvaTec; Peel Hunt cuts Harbour Energy

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
5 Sep 2023 14:02

Pent-up private Wegovy demand prompts UK availability concerns

Britain is Novo's fifth market for Wegovy

*

Read more
5 Sep 2023 12:58

Pent-up private Wegovy demand prompts UK availability concerns

Britain is Novo's fifth market for Wegovy

*

Read more
5 Sep 2023 12:38

CORRECTED (OFFICIAL)-Pent-up private Wegovy demand prompts UK availability concerns

Britain is Novo's fifth market for Wegovy

*

Read more
5 Sep 2023 06:00

Pent-up private Wegovy demand prompts UK availability concerns

Britain is Novo's fifth market for Wegovy

*

Read more
4 Sep 2023 16:27

Wegovy makes UK weight-loss debut even as Novo struggles with supplies

Novo says Wegovy launch in UK 'controlled and limited'

*

Read more
4 Sep 2023 11:05

British private insurer Aviva will not pay for Novo's weight-loss drug Wegovy

LONDON, Sept 4 (Reuters) - British private insurer Aviva has said it will not pay for treatment with Novo Nordisk's weight-loss drug Wegovy, which launched in the UK on Monday.

Read more
31 Aug 2023 17:02

Miners drag FTSE 100 lower to snap 6-day winning streak

Glencore among top losers on FTSE 100

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.